‘The undruggable became druggable’: a gamechanging treatment for the world’s deadliest cancer
A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a gamechanger and one of the biggest breakthroughs in decades. To find out more about how daraxonrasib works and how life-changing it could be for patients,…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Science Weekly
See all episodes →
Similar episodes from other shows
More like Science Weekly →
Lung cancer: looking at the latest developments
Promising new treatments for pancreatic cancer and ALS
New Treatment Saves Children With Terminal Brain Cancer
The Happy Pod: Kinder medicine for millions of cancer patients
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.